| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Krebs Biochemicals and Industries Limited (NSE: KREBSBIO)
KREBSBIO Technical Analysis
1.5
| As on 24th Apr 2024 KREBSBIO SHARE Price closed @ 72.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 77.77 & Buy for SHORT-TERM with Stoploss of 70.60 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KREBSBIOSHARE Price
| Open | 74.70 | Change | Price | % |
| High | 74.70 | 1 Day | -0.20 | -0.28 |
| Low | 71.55 | 1 Week | 0.80 | 1.12 |
| Close | 72.20 | 1 Month | 5.55 | 8.33 |
| Volume | 3049 | 1 Year | -2.70 | -3.60 |
| 52 Week High 213.05 | 52 Week Low 52.05 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.10 | -9.03% |
| SAIL | 164.65 | 8.14% |
| YESBANK | 25.45 | -0.78% |
| TATASTEEL | 165.55 | 2.73% |
| IRFC | 149.00 | 0.85% |
| SOUTHBANK | 29.10 | 1.04% |
| MRPL | 248.70 | 10.75% |
| SUZLON | 41.80 | -0.12% |
| BEL | 236.50 | 0.92% |
| RAMASTEEL | 14.00 | 2.56% |
NSE INDIA Top Gainers Stocks
| ROML | 63.05 | 19.98% |
| COMPUSOFT | 35.20 | 19.93% |
| SHRADHA | 78.55 | 19.83% |
| STEELCITY | 102.95 | 19.78% |
| WEIZMANIND | 142.25 | 19.59% |
| TEMBO | 240.90 | 18.61% |
| CHENNPETRO | 1075.00 | 15.82% |
| YUKEN | 1180.65 | 13.81% |
| ORIENTCEM | 230.50 | 12.85% |
| AEGISCHEM | 604.50 | 12.41% |
NSE INDIA Top Losers Stocks
| KREBSBIO Daily Charts |
KREBSBIO Intraday Charts |
Whats New @ Bazaartrend |
KREBSBIO Free Analysis |
|
|
KREBSBIO Important Levels Intraday
| RESISTANCE | 78.27 |
| RESISTANCE | 76.32 |
| RESISTANCE | 75.12 |
| RESISTANCE | 73.92 |
| SUPPORT | 70.48 |
| SUPPORT | 69.28 |
| SUPPORT | 68.08 |
| SUPPORT | 66.13 |
KREBSBIO Target April 2024
| 4th UP Target | 97.43 |
| 3rd UP Target | 89.18 |
| 2nd UP Target | 84.08 |
| 1st UP Target | 78.98 |
| 1st DOWN Target | 64.42 |
| 2nd DOWN Target | 59.32 |
| 3rd DOWN Target | 54.22 |
| 4th DOWN Target | 45.97 |
KREBSBIO Weekly Target
| 4th UP Target | 87.27 |
| 3rd UP Target | 81.96 |
| 2nd UP Target | 78.67 |
| 1st UP Target | 75.39 |
| 1st DOWN Target | 66.01 |
| 2nd DOWN Target | 62.73 |
| 3rd DOWN Target | 59.44 |
| 4th DOWN Target | 54.13 |
KREBSBIO Target2024
| 4th UP Target | 234.05 |
| 3rd UP Target | 184.12 |
| 2nd UP Target | 153.25 |
| 1st UP Target | 122.39 |
| 1st DOWN Target | 34.31 |
| 2nd DOWN Target | 3.45 |
| 3rd DOWN Target | -27.42 |
| 4th DOWN Target | -77.35 |
Krebs Biochemicals and Industries Limited ( NSE INDIA Symbol : KREBSBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KREBSBIO Synopsis Technicals View
| 50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
| 100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
| 200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 31.65 | Sideways | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -76.58 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Short Sell | 88.06 | |
| 10 Day Avg Volume | Traded -91.88 % Less then 10 Day Average Volume | ||
KREBSBIO Other Details
| Segment | EQ | |
| Market Capital | 3557498880.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
KREBSBIO Address
 |
||
KREBSBIO Latest News
KREBSBIO Business Profile
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India. Address: Maas Heights, Hyderabad, India, 500034
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service